The impact of COVID-19 on kidney transplantation and the kidney transplant recipient - One year into the pandemic

The COVID-19 pandemic has significantly changed the landscape of kidney transplantation in the United States and worldwide. In addition to adversely impacting allograft and patient survival in postkidney transplant recipients, the current pandemic has affected all aspects of transplant care, including transplant referrals and listing, organ donation rates, organ procurement and shipping, and waitlist mortality. Critical decisions were made during this period by transplant centers and individual transplant physicians taking into consideration patient safety and resource utilization. As countries have begun administering the COVID vaccines, new and important considerations pertinent to our transplant population have arisen. This comprehensive review focuses on the impact of COVID-19 on kidney transplantation rates, mortality, policy decisions, and the clinical management of transplanted patients infected with COVID-19.

Automated summary

The COVID-19 pandemic has significantly impacted kidney transplantation, affecting patient and allograft survival, transplant referrals, organ donation rates, and clinical management decisions. Transplant centers and physicians have made critical decisions considering patient safety and resource utilization. New considerations have arisen with the administration of COVID vaccines.